subscribe to our newsletter sign up
Bakers and Clutz advise on pharmaceutical offload

Bakers and Clutz advise on pharmaceutical offload

Baker & McKenzie and Clayton Utz advise on the sale of Australian-based iNova Pharmaceuticals to Canada-based Valeant Pharmaceuticals.

Firms: Baker & McKenzie (Valeant Pharmaceuticals); Clayton Utz (Ironbridge and Archer Capital)

Deal: NYSE-listed, Canada-based Valeant Pharmaceuticals acquisition of Australian-based iNova Pharmaceuticals from Ironbridge and Archer Capital. Deal officially closed on 21 December

Area: M&A

Value: $625 million upfront and up to an additional $75 million in potential milestones 

Key players: The Bakers team was led by Sydney-based partner David Egan and associate Michael Dearden

Promoted content
Recommended by Spike Native Network